Thursday, April 04, 2024 12:33:19 PM
Recent KTRA News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/16/2024 04:15:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 08:20:08 PM
- Kintara Therapeutics Announces Correction to Prior Announcement Regarding CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024 • PR Newswire (US) • 10/15/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 12:30:07 PM
- Kintara Therapeutics Announces Record Date for CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024 • PR Newswire (US) • 10/14/2024 12:30:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/08/2024 08:05:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 08:05:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 11:05:07 AM
- Kintara Therapeutics Announces Fiscal 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 10/08/2024 11:00:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/07/2024 09:19:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/04/2024 08:10:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 08:05:09 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/30/2024 09:20:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/25/2024 09:27:10 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/25/2024 09:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 09:00:09 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/24/2024 12:35:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 12:30:08 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/20/2024 08:20:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:15:07 PM
- Kintara Therapeutics Announces Adjournment of Special Meeting of Stockholders until October 4, 2024 • PR Newswire (US) • 09/20/2024 01:25:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/18/2024 12:40:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 12:35:07 PM
- Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences • PR Newswire (US) • 09/18/2024 12:30:00 PM
- Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences • PR Newswire (US) • 09/18/2024 12:30:00 PM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM
Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM